Latest Insider Transactions at Nuvalent, Inc. (NUVL)
This section provides a real-time view of insider transactions for Nuvalent, Inc. (NUVL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nuvalent, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nuvalent, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 20
2025
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.24%
|
$470,000
$94.91 P/Share
|
|
Oct 20
2025
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.46%
|
$30,000
$6.89 P/Share
|
|
Oct 16
2025
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
12,376
-7.19%
|
$1,126,216
$91.47 P/Share
|
|
Oct 16
2025
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,376
+16.76%
|
$74,256
$6.89 P/Share
|
|
Oct 16
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-2.52%
|
$2,457,000
$91.44 P/Share
|
|
Oct 16
2025
|
James Richard Porter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+8.91%
|
$486,000
$18.93 P/Share
|
|
Oct 15
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,683
-2.65%
|
$143,055
$85.57 P/Share
|
|
Oct 15
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,683
+2.59%
|
$30,294
$18.93 P/Share
|
|
Oct 15
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
14,205
-17.72%
|
$1,278,450
$90.04 P/Share
|
|
Oct 15
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,205
+5.84%
|
$553,995
$39.71 P/Share
|
|
Oct 15
2025
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,624
-24.14%
|
$1,390,536
$89.98 P/Share
|
|
Oct 15
2025
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,624
+19.45%
|
$93,744
$6.89 P/Share
|
|
Oct 14
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,433
-1.2%
|
$209,238
$86.16 P/Share
|
|
Oct 14
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,433
+1.19%
|
$60,825
$25.37 P/Share
|
|
Oct 14
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-6.6%
|
$1,740,000
$87.24 P/Share
|
|
Oct 14
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+19.66%
|
$360,000
$18.93 P/Share
|
|
Oct 13
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,637
-10.38%
|
$679,693
$89.81 P/Share
|
|
Oct 13
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,637
+3.43%
|
$297,843
$39.71 P/Share
|
|
Oct 13
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-8.75%
|
$1,760,000
$88.62 P/Share
|
|
Oct 13
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+11.47%
|
$240,000
$12.91 P/Share
|
|
Oct 01
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-12.41%
|
$1,700,000
$85.9 P/Share
|
|
Oct 01
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.7%
|
$240,000
$12.91 P/Share
|
|
Sep 30
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-24.47%
|
$1,700,000
$85.06 P/Share
|
|
Sep 30
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+19.66%
|
$120,000
$6.89 P/Share
|
|
Sep 29
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,588
-10.95%
|
$644,980
$85.01 P/Share
|
|
Sep 29
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,588
+9.87%
|
$45,528
$6.89 P/Share
|
|
Sep 29
2025
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.59%
|
$332,000
$83.27 P/Share
|
|
Sep 29
2025
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+7.14%
|
$108,000
$27.85 P/Share
|
|
Sep 15
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-3.35%
|
$2,133,000
$79.28 P/Share
|
|
Sep 15
2025
|
James Richard Porter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+8.91%
|
$486,000
$18.93 P/Share
|
|
Sep 10
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,725
-5.35%
|
$290,550
$78.83 P/Share
|
|
Sep 10
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,725
+1.77%
|
$93,125
$25.37 P/Share
|
|
Aug 29
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,007
+3.72%
|
$0
$0.98 P/Share
|
|
Aug 25
2025
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,000
-2.61%
|
$296,000
$74.84 P/Share
|
|
Aug 25
2025
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+7.14%
|
$108,000
$27.85 P/Share
|
|
Aug 15
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-3.33%
|
$2,052,000
$76.03 P/Share
|
|
Aug 15
2025
|
James Richard Porter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+8.91%
|
$486,000
$18.93 P/Share
|
|
Aug 07
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,500
-8.28%
|
$407,000
$74.85 P/Share
|
|
Aug 07
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+2.7%
|
$137,500
$25.37 P/Share
|
|
Jul 30
2025
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,000
-7.69%
|
$320,000
$80.36 P/Share
|
|
Jul 30
2025
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+7.14%
|
$108,000
$27.85 P/Share
|
|
Jul 16
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,700
-19.23%
|
$1,249,500
$85.1 P/Share
|
|
Jul 16
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,700
+16.13%
|
$264,600
$18.93 P/Share
|
|
Jul 15
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-2.5%
|
$2,241,000
$83.11 P/Share
|
|
Jul 15
2025
|
James Richard Porter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+8.91%
|
$486,000
$18.93 P/Share
|
|
Jul 15
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,300
-2.03%
|
$445,200
$84.23 P/Share
|
|
Jul 15
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+7.33%
|
$95,400
$18.93 P/Share
|
|
Jul 10
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,500
-4.15%
|
$440,000
$80.43 P/Share
|
|
Jul 10
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+2.65%
|
$137,500
$25.37 P/Share
|
|
Jul 09
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,145
-1.7%
|
$173,745
$81.49 P/Share
|